US 10106610
Antibodies comprising chimeric constant domains
granted A61PA61P43/00
Quick answer
US patent 10106610 (Antibodies comprising chimeric constant domains) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P43/00